Carl Zeiss Meditec AG

Introducing our member:

Company Profile:
Carl Zeiss Meditec AG (ISIN: DE0005313704), listed on the TecDAX of the German Stock Exchange, is one of the world’s leading providers of medical technology. The company delivers innovative technologies and application-oriented solutions that enable physicians to improve their patients’ quality of life. For the diagnosis and treatment of eye diseases, the company offers comprehensive solutions, including implants and consumables. In microsurgery, the company provides innovative visualization solutions. Carl Zeiss Meditec is part of the Medical Technology division, which generated revenue of 1.647 billion euros in fiscal year 2019/20 with 5,461 employees worldwide.

The company is headquartered in Jena, Germany. In addition to other branches in Germany, more than 50 percent of the company’s employees are based at locations in the United States, Japan, Spain, and France. The Center for Application and Research India (CARIn) in Bangalore, India, and the Carl Zeiss Innovations Center for Research and Development in Shanghai, China, strengthen the company’s presence in these rapidly growing countries. Approximately 41 percent of Carl Zeiss Meditec’s shares are held by the public. The remaining approximately 59 percent are held by Carl Zeiss AG, a leading global group of companies in the optical and optoelectronic industries.